DXCM DexCom, Inc. - Common Stock
$92,19
Prix · Aoû 24, 2026
Données fondamentales au Jul 30, 2026
Fourchette 52 semaines
$54–$93
99% of range
Note des analystes
BUY
36 analysts
Objectif de cours
$94
+2% upside
P/E (TTM)
44.2
ROE
31.4%
Marge nette
17.9%
À propos de DexCom, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Lire la suite
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
DXCM Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$92.19
Capitalisation Boursière
$35.57B
P/E (TTM)
44.2
BPA (TTM)
$2.09
Revenus (TTM)
$4.66B
Rendement div.
—
ROE
31.4%
Dette/Capitaux propres
—
Fourchette 52 semaines
$54 – $93
DXCM Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$4.66B
2016-12-31
→
2025-12-31
BPA
$2.09
2017-12-31
→
2025-12-31
Flux de trésorerie libre
$1.08B
2016-12-31
→
2025-12-31
Marges
17.9%
2018-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
DXCM
Médiane des pairs
P/E (TTM)
44.2
26.3
P/S (TTM)
7.6
4.4
P/B
13.0
5.3
Price / FCF (Cours / FCF)
33.0
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
DXCM
Médiane des pairs
Gross Margin (Marge Brute)
60.1%
63.1%
Operating Margin (Marge d'exploitation)
19.6%
—
Net Profit Margin (Marge nette)
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
DXCM
Médiane des pairs
Current Ratio (Ratio de liquidité)
1.9
1.7
Quick Ratio (Ratio de liquidité réduite)
1.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
DXCM
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
15.6%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
17.0%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
19.3%
—
EPS YoY (BPA Année/Année)
47.2%
—
Net Income YoY (Bénéfice net YoY)
45.1%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
DXCM
Médiane des pairs
DXCM Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
36 analystes
- Achat fort 15 41,7%
- Achat 16 44,4%
- Conserver 5 13,9%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
25 analystes · 2026-08-21
Médiane
$94.00
Maintenant
$92.19
Bas
$79.00
Haut
$115.00
Objectif médian
$94.00
+2,0%
Objectif moyen
$94.12
+2,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.05%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.70 | $0.62 | 0.08% |
| 31 mars 2026 | $0.56 | $0.48 | 0.08% |
| 31 décembre 2025 | $0.56 | $0.48 | 0.08% |
| 30 septembre 2025 | $0.61 | $0.58 | 0.03% |
| 30 juin 2025 | $0.48 | $0.45 | 0.03% |
| 31 mars 2025 | $0.32 | $0.33 | -0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Bilan 26
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Taux de croissance 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Compte de résultat 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Flux de trésorerie 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Marge Brute % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Marge d'exploitation % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Résultat net | $836M | $576M | $542M | $341M | $217M |
| BPA dilué | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Ratio de liquidité réduite | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $1.08B | $631M | $512M | $305M | $53M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 088 déclarants · $16.0B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 124 (-39 vs T. préc.) | 96 (+5 vs T. préc.) | 394 (+24 vs T. préc.) | 356 (+8 vs T. préc.) | -6.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 697 876 797 | 25 209 752 | 10,61% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 323 867 969 | 19 656 540 | 8,27% | Actions |
| STATE STREET CORP | $1 237 947 284 | 18 380 806 | 7,73% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $751 533 926 | 11 199 611 | 4,69% | Actions |
| ALLIANCEBERNSTEIN L.P. | $734 346 085 | 11 693 409 | 4,59% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $545 031 559 | 8 092 525 | 3,40% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462 914 937 | 6 873 273 | 2,89% | Actions |
| NORGES BANK | $462 565 862 | 6 868 090 | 2,89% | Actions |
| Castle Hook Partners LP | $260 667 534 | 3 870 342 | 1,63% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231 614 091 | 3 438 962 | 1,45% | Actions |
| AMERICAN CENTURY COMPANIES INC | $206 860 340 | 3 071 423 | 1,29% | Actions |
| JANUS HENDERSON GROUP PLC | $162 720 013 | 2 591 083 | 1,02% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $152 790 681 | 2 268 607 | 0,95% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $149 327 006 | 2 217 179 | 0,93% | Actions |
| Employees Provident Fund Board | $147 498 453 | 2 190 029 | 0,92% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129 989 908 | 2 069 903 | 0,81% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $114 711 656 | 1 703 218 | 0,72% | Actions |
| BLAIR WILLIAM & CO/IL | $112 182 565 | 1 665 665 | 0,70% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $109 834 111 | 1 630 796 | 0,69% | Actions |
| RAYMOND JAMES FINANCIAL INC | $102 869 971 | 1 527 394 | 0,64% | Actions |
| BANK OF AMERICA CORP /DE/ | $97 103 277 | 1 441 771 | 0,61% | Actions |
| AMERIPRISE FINANCIAL INC | $93 336 259 | 1 385 802 | 0,58% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $92 130 221 | 1 367 932 | 0,58% | Actions |
| DSM CAPITAL PARTNERS LLC | $91 537 742 | 1 359 135 | 0,57% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89 939 931 | 1 335 411 | 0,56% | Actions |
| ROYAL BANK OF CANADA | $88 321 000 | 1 311 368 | 0,55% | Actions |
| GOLDMAN SACHS GROUP INC | $87 360 493 | 1 297 112 | 0,55% | Actions |
| CI INVESTMENTS INC. | $86 724 103 | 1 287 663 | 0,54% | Actions |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85 826 193 | 1 274 331 | 0,54% | Actions |
| BANK OF NOVA SCOTIA | $85 283 937 | 1 266 285 | 0,53% | Actions |
| DNB Asset Management AS | $84 543 377 | 1 255 284 | 0,53% | Actions |
| Nearwater Capital Markets, Ltd | $84 187 500 | 1 250 000 | 0,53% | Actions |
| Stephens Investment Management Group LLC | $81 126 645 | 1 204 553 | 0,51% | Actions |
| Swedbank AB | $78 528 215 | 1 165 972 | 0,49% | Actions |
| BlackRock, Inc. | $77 389 460 | 1 149 064 | 0,48% | Actions |
| FMR LLC | $77 274 023 | 1 147 350 | 0,48% | Actions |
| CITADEL ADVISORS LLC | $75 864 589 | 1 126 423 | 0,47% | Actions |
| FIRST TRUST ADVISORS LP | $74 838 523 | 1 111 188 | 0,47% | Actions |
| HSBC HOLDINGS PLC | $73 861 872 | 1 080 800 | 0,46% | Option d'achat |
| Swiss National Bank | $73 108 425 | 1 085 500 | 0,46% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $71 040 241 | 1 054 792 | 0,44% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67 343 265 | 999 900 | 0,42% | Actions |
| CITADEL ADVISORS LLC | $64 656 000 | 960 000 | 0,40% | Option de vente |
| Legal & General Group Plc | $64 638 083 | 959 734 | 0,40% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $64 478 600 | 957 366 | 0,40% | Actions |
| BAILLIE GIFFORD & CO | $63 928 755 | 949 202 | 0,40% | Actions |
| CIBC Bancorp USA Inc. | $62 958 645 | 932 286 | 0,39% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61 865 555 | 918 568 | 0,39% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $59 044 465 | 876 681 | 0,37% | Actions |
| Chicago Capital, LLC | $58 393 062 | 867 009 | 0,36% | Actions |
| Fisher Funds Management LTD | $56 637 983 | 840 950 | 0,35% | Actions |
| Vanguard Global Advisers, LLC | $56 107 871 | 833 079 | 0,35% | Actions |
| JANE STREET GROUP, LLC | $56 062 140 | 832 400 | 0,35% | Option d'achat |
| Bellevue Group AG | $55 394 634 | 822 489 | 0,35% | Actions |
| Tri Locum Partners LP | $55 259 261 | 820 479 | 0,35% | Actions |
| RHUMBLINE ADVISERS | $51 735 803 | 768 165 | 0,32% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $51 168 667 | 759 743 | 0,32% | Actions |
| UBS Group AG | $51 066 858 | 758 231 | 0,32% | Actions |
| Allianz Asset Management GmbH | $50 820 963 | 809 251 | 0,32% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50 518 000 | 750 088 | 0,32% | Actions |
| BARCLAYS PLC | $50 351 331 | 747 607 | 0,31% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $49 968 851 | 741 928 | 0,31% | Actions |
| TWO SIGMA ADVISERS, LP | $49 649 804 | 748 076 | 0,31% | Actions |
| Smith Group Asset Management, LLC | $47 235 720 | 701 347 | 0,30% | Actions |
| NATIONAL BANK OF CANADA /FI/ | $46 761 576 | 694 307 | 0,29% | Actions |
| Assenagon Asset Management S.A. | $46 716 317 | 693 635 | 0,29% | Actions |
| NEUBERGER BERMAN GROUP LLC | $46 117 886 | 684 750 | 0,29% | Actions |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44 760 810 | 664 600 | 0,28% | Actions |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44 759 530 | 664 581 | 0,28% | Actions |
| Capital International Investors | $44 585 633 | 661 999 | 0,28% | Actions |
| CAPITAL FUND MANAGEMENT S.A. | $44 543 875 | 661 379 | 0,28% | Actions |
| Pictet Asset Management Holding SA | $44 534 379 | 661 238 | 0,28% | Actions |
| National Pension Service | $44 471 811 | 660 309 | 0,28% | Actions |
| California Public Employees Retirement System | $42 988 899 | 638 291 | 0,27% | Actions |
| Korea Investment CORP | $42 608 237 | 632 639 | 0,27% | Actions |
| ING GROEP NV | $41 334 513 | 613 727 | 0,26% | Actions |
| Susquehanna Portfolio Strategies, LLC | $41 226 753 | 612 127 | 0,26% | Actions |
| MIG Capital, LLC | $40 190 154 | 605 547 | 0,25% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39 472 718 | 584 004 | 0,25% | Actions |
| Quantinno Capital Management LP | $39 303 248 | 583 567 | 0,25% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36 898 831 | 587 561 | 0,23% | Actions |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36 855 267 | 547 220 | 0,23% | Actions |
| FACTORY MUTUAL INSURANCE CO | $36 222 851 | 537 830 | 0,23% | Actions |
| Woodline Partners LP | $36 146 880 | 536 702 | 0,23% | Actions |
| Parkman Healthcare Partners LLC | $36 016 557 | 534 767 | 0,22% | Actions |
| MARSHALL WACE, LLP | $35 884 349 | 532 804 | 0,22% | Actions |
| Walleye Trading LLC | $35 823 465 | 531 900 | 0,22% | Option d'achat |
| EVENTIDE ASSET MANAGEMENT, LLC | $33 574 377 | 498 202 | 0,21% | Actions |
| Blue Sparrow, LLC /DE | $32 368 410 | 480 600 | 0,20% | Actions |
| Trexquant Investment LP | $31 938 380 | 474 215 | 0,20% | Actions |
| Cubist Systematic Strategies, LLC | $31 905 647 | 474 151 | 0,20% | Actions |
| UBS Group AG | $31 896 960 | 473 600 | 0,20% | Option de vente |
| Mitsubishi UFJ Trust & Banking Corp | $31 227 164 | 463 655 | 0,20% | Actions |
| USS Investment Management Ltd | $30 910 132 | 459 050 | 0,19% | Actions |
| OFI INVEST ASSET MANAGEMENT | $29 454 211 | 500 000 | 0,18% | Actions |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29 397 534 | 436 489 | 0,18% | Actions |
| ProShare Advisors LLC | $28 566 636 | 424 152 | 0,18% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28 528 135 | 427 840 | 0,18% | Actions |
| SIRIOS CAPITAL MANAGEMENT L P | $28 315 152 | 420 418 | 0,18% | Actions |
| Bridgewater Associates, LP | $27 002 568 | 400 929 | 0,17% | Actions |
Initiés de la société 60 initiés · 36 dirigeants · 24 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 mai 2026 F | 420 359 | 2 | 0 | $1 001 761 |
| Andrew P Rasdal | President & CEO | 2 mai 2006 M | 2 944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 mars 2017 S | 8 452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 mai 2007 A | 26 255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 septembre 2021 S | 19 280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | 20 juillet 2026 S | 328 970 | 0 | 3 | $-5 895 098 |
| Jon Coleman | EVP, Chief Commercial Officer | 4 juin 2026 S | 95 450 | 0 | 2 | $-722 628 |
| Sadie Stern | EVP Chief People & Culture Off | 22 mai 2026 F | 130 059 | 0 | 1 | $-117 280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 22 mai 2026 F | 151 841 | 0 | 1 | $-357 796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 janvier 2025 S | 42 044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 mars 2024 S | 66 641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 décembre 2023 D | 48 949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 décembre 2023 D | 58 469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 novembre 2023 S | 124 775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9 novembre 2023 S | 47 725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 septembre 2023 D | 48 453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 mars 2023 D | 208 023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 mars 2023 D | 50 908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9 mai 2022 S | 13 675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9 mars 2022 D | 13 789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9 septembre 2021 S | 16 254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 mars 2021 S | 6 654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9 septembre 2020 D | 34 784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 mars 2020 S | 38 584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 juillet 2018 S | 50 882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9 mars 2017 M | 84 034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 novembre 2010 P | 3 387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 août 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 mars 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 mars 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 mars 2010 A | 18 741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 mai 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 mars 2008 A | 53 125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2 novembre 2007 A | 10 967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2 août 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9 mars 2007 A | — | 0 | 0 | $0 |
| Bridgette P Heller | Administrateur | 12 août 2026 S | 29 570 | 0 | 4 | $-277 672 |
| Mark G Foletta | Administrateur | 3 août 2026 S | 48 852 | 0 | 4 | $-627 183 |
| Albert Frederick Osterloh IV | Administrateur | 28 mai 2026 A | 8 691 | 0 | 0 | $0 |
| Euan A. Ashley | Administrateur | 28 mai 2026 A | 12 731 | 0 | 0 | $0 |
| Rimma Driscoll | Administrateur | 28 mai 2026 A | 17 319 | 0 | 0 | $0 |
| Kyle Malady | Administrateur | 28 mai 2026 A | 28 242 | 0 | 1 | $-53 934 |
| Richard Alexander Collins | Administrateur | 28 mai 2026 A | 5 605 | 0 | 2 | $-389 410 |
| Renee D Gala | Administrateur | 28 mai 2026 A | 12 486 | 0 | 0 | $0 |
| Steven R Altman | Administrateur | 28 mai 2026 A | 5 565 | 0 | 0 | $0 |
| Karen M Dahut | Administrateur | 8 mai 2025 G | 17 779 | 0 | 0 | $0 |
| Eric Topol | Administrateur | 8 mai 2025 G | 380 545 | 0 | 0 | $0 |
| Barbara Kahn | Administrateur | 18 mai 2024 G | 22 575 | 0 | 0 | $0 |
| Jay S Skyler | Administrateur | 18 mai 2023 G | 63 348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Administrateur | 1 septembre 2016 S | 52 820 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 209 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| EKG · First Trust Exchange-Traded Fund II | 7,02% | 2 933 NS | 30 juin 2026 | N-PORT |
| TMFM · RBB Fund, Inc. | 5,18% | 81 981 NS | 31 mai 2026 | N-PORT |
| HEAL · Global X Funds | 4,89% | 16 599 NS | 31 mai 2026 | N-PORT |
| IHI · iShares Trust | 4,81% | 1 837 351 SH | 21 août 2026 | Quotidien |
| SNSR · Global X Funds | 4,74% | 161 491 NS | 31 mai 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,79% | 7 621 NS | 31 mai 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2,33% | 112 503 NS | 31 mai 2026 | N-PORT |
| MDEV · First Trust Exchange-Traded Fund VI | 2,16% | 614 NS | 30 juin 2026 | N-PORT |
| FTGS · First Trust Exchange-Traded Fund | 2,09% | 387 918 NS | 30 juin 2026 | N-PORT |
| AGNG · Global X Funds | 2,01% | 22 316 NS | 31 mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,92% | 13 512 NS | 31 mai 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,91% | 5 848 NS | 30 avril 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 952 NS | 30 avril 2026 | N-PORT |
| QQEW · First Trust Exchange-Traded Fund | 1,79% | 482 439 NS | 30 juin 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,75% | 158 693 SH | 21 août 2026 | Quotidien |
| QQXT · First Trust Exchange-Traded Fund | 1,70% | 41 963 NS | 30 juin 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,53% | 387 504 SH | 21 août 2026 | Quotidien |
| TMFX · RBB Fund, Inc. | 1,37% | 5 955 NS | 31 mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6 533 NS | 31 mai 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,17% | 15 853 NS | 31 mai 2026 | N-PORT |
| FSGS · First Trust Exchange-Traded Fund VI | 1,06% | 4 466 NS | 30 juin 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1,01% | 10 206 NS | 31 mai 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1,01% | 302 231 NS | 31 mai 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1,00% | 18 376 NS | 31 mai 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,99% | 1 867 NS | 30 avril 2026 | N-PORT |
| IWP · iShares Trust | 0,98% | 2 211 186 SH | 21 août 2026 | Quotidien |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,97% | 17 329 NS | 30 avril 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,92% | 6 459 NS | 30 avril 2026 | N-PORT |
| SDG · iShares Trust | 0,92% | 18 232 SH | 21 août 2026 | Quotidien |
| MMID · MFS Active Exchange Traded Funds Tr… | 0,91% | 4 208 NS | 31 mai 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,84% | 3 888 NS | 30 avril 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,80% | 163 528 NS | 30 avril 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,76% | 296 418 NS | 31 mai 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,67% | 56 679 NS | 31 mai 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,64% | 1 196 NS | 30 avril 2026 | N-PORT |
| QNXT · iShares Trust | 0,63% | 2 014 SH | 21 août 2026 | Quotidien |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2 956 203 SH | 19 août 2026 | Quotidien |
| IYH · iShares Trust | 0,53% | 228 594 SH | 21 août 2026 | Quotidien |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,49% | 1 039 208 SH | 21 août 2026 | Quotidien |
| IMCG · iShares Trust | 0,47% | 211 934 SH | 21 août 2026 | Quotidien |
| IXJ · iShares Trust | 0,42% | 203 560 SH | 21 août 2026 | Quotidien |
| RXL · ProShares Trust | 0,41% | 4 013 NS | 31 mai 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,41% | 2 617 NS | 30 avril 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 56 496 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,38% | 1 156 710 SH | 19 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,38% | 179 798 NS | 30 avril 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23 742 SH | 19 août 2026 | Quotidien |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,33% | 4 233 NS | 31 mai 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,33% | 18 233 NS | 31 mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,33% | 7 675 NS | 30 avril 2026 | N-PORT |